[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Filters

Search
Categories
2
1
5
11
167
Publishers
186
Regions
2
1
Price
Date
Pages
Offers

Black Swan Analysis limited: Market Research Reports

Black Swan Analysis is a provider of insightful commercialization ideas for the clients engaged in the healthcare sector.

The company delivers one-of-a-kind solutions, reliable epidemiology data, market and product overviews, and business opportunity evaluation for the clients who want to increase their capacity in producing and selling healthcare products.

Black Swan Analysis is an unrestricted resource of avant-garde solutions to the clients who want to upgrade their performance at the healthcare market. Our experience and ability to penetrate to the core of the problem enable us to produce exclusive market research reports that contain a variety of useful information including:
  • Product profile
  • SWOT analysis
  • Growth drivers
  • Market share
  • Supply and demand channels
  • Analysis of Competitors’ products and services
  • New application areas
To ensure precise forecasting, we explore and analyze a vast variety of epidemiological and pathological data and study disease environment. Our clients can access disease epidemiology information and receive the accurate evaluation of the pricing policies of proprietors in the healthcare and pharmaceutical business.

We do not let our customers leave our company with half-baked information and weak decisions. Clients with unmet expectations are not about us. They appreciate Black Swan Analysis for adaptable solutions, proficiency, cost-effectiveness, and unique methodologies.

We help our pharmaceutical and healthcare partners recharge their capacities and increase their competitive rates. Our service algorithm is to work in close cooperation with the customer. Consistent inclusive communication helps us approach every commercial challenge expertly and invent unique business solutions.
Publications found: 186
Sort by:
Epiomic Epidemiology Series: Addison's disease Forecast in 22 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Forecast Report on Addison’s Disease in 22 Major Markets Addison's disease (AD) is a chronic and rare endocrinal disorder, caused by ... up-to-date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

August 2018 70 pages
Epiomic Epidemiology Series: Alpha-1 anti-trypsin deficiency Forecast in 18 Major Markets 2018–2028 US$ 5,800.00

... Epiomic Epidemiology Forecast Report on Alpha-1 Anti-Trypsin Deficiency Forecast in 18 Major Markets Alpha-1 anti-trypsin deficiency (AATD) is an inherited, rare condition that causes a complete or partial reduction in the activity of alpha-1 anti-trypsin ... such as in alpha 1-anti-trypsin deficiency), neutrophil ...

August 2018 52 pages
Epiomic Epidemiology Series: Congenital adrenal hyperplasia Forecast in 31 Major Markets 2018–2028 US$ 6,000.00

... Epiomic Epidemiology Forecast Report on Congenital Adrenal Hyperplasia in 31 Major Markets Congenital adrenal hyperplasia (CAH) is a group of genetic disorders associated with deficiencies of several adrenal ... information form patient registries, clinical trials and epidemiology studies. All of the sources used ...

August 2018 84 pages
Epiomic Epidemiology Series: Cushing’s syndrome Forecast in 25 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Forecast Report on Cushing’s Syndrome in 25 Major Markets Cushing’s syndrome is a multisystem disorder associated ... conditions on the prevalent population of Cushing’s syndrome patients. Identification of Cushing’s syndrome patient sub-populations that require treatment. ...

August 2018 88 pages
Epiomic Epidemiology Series: Friedreich’s ataxia Forecast in 28 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Forecast Report on Friedreich’s Ataxia in 28 Major Markets Friedreich’s ataxia (FA) is a rare genetic neurodegenerative disorder with the ... up-to-date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

August 2018 84 pages
Epiomic Epidemiology Series: Growth hormone deficiency Forecast in 19 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Growth Hormone Deficiency in 19 Major Markets Growth Hormone Deficiency (GHD) results from the destruction ... tissue and is characterized by the inadequate secretion of growth hormone (GH) from the anterior pituitary gland. GHD can occur ...

August 2018 80 pages
Epiomic Epidemiology Series: Prader–willi syndrome Forecast in 21 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Prader–Willi Syndrome in 21 Major Markets Prader–Willi syndrome (PWS) is a genetic disease caused by the loss of function ... date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

August 2018 80 pages
Epiomic Epidemiology Series: Primary immunodeficiency diseases Forecast in 23 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Primary Immunodeficiency Diseases in 23 Major Markets Primary immunodeficiency diseases (PID) are a group of ... co-morbidities for PID include: Severe Congenital Immunodeficiency (SCID) Recurrent or persistent infections Allergic manifestations ...

August 2018 66 pages
Epiomic Epidemiology Series: Wilson’s disease Forecast in 28 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Forecast Report on Wilson’s Disease in 28 Major Markets Wilson's disease, also known as progressive lenticular degeneration, is a ... patient recruitment for various countries. Identification of Wilson's disease patient sub-populations that require treatment. Better ...

August 2018 100 pages
Epiomic Epidemiology Series: Angina Pectoris Forecast in 20 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Angina Pectoris in 20 Major Markets Angina Pectoris (AP) is the term given to the pain or discomfort felt ... up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data ...

July 2018 68 pages
Epiomic Epidemiology Series: Aortic Stenosis Forecast in 25 Major Markets 2018–2028 US$ 5,800.00

... Analysis Epiomic Epidemiology Series Forecast Report on Aortic Stenosis in 25 Major Markets Aortic Stenosis (AS) is the occlusion or loss of aortic valve surface area resulting in stenosis of the aortic valve. ... form patient registries, clinical trials and epidemiology studies. All of the sources used ...

July 2018 136 pages
Epiomic Epidemiology Series: Atrial Fibrillation Forecast in 19 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Atrial Fibrillation in 19 Major Markets Atrial Fibrillation (AF) is the most prevalent type of supraventricular arrhythmia ... date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

July 2018 76 pages
Epiomic Epidemiology Series: Hypertension Forecast in 19 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Hypertension in 19 Major Markets Hypertension (high blood pressure) is a common condition in which the ... country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Hypertension include: Chronic heart failure Chronic ...

July 2018 70 pages
Epiomic Epidemiology Series: Hypertrophic Cardiomyopathy Forecast in 26 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Hypertrophic Cardiomyopathy in 26 Major Markets Hypertrophic cardiomyopathy (HCM) is a disease that contains an autosomal ... date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

July 2018 112 pages
Epiomic Epidemiology Series: Peripheral Arterial Disease Forecast in 22 Major Markets 2018–2028 US$ 5,800.00

... Swan Analysis Epiomic Epidemiology Series Forecast Report on Peripheral Arterial Disease (PAD) in 22 Major Markets Peripheral Arterial disease (PAD) is an occlusion of the peripheral arteries and is ... PAD can also be known as peripheral arterial occlusive disease, arteriosclerosis obliterans, lower extremity ...

July 2018 102 pages
Epiomic Epidemiology Series: Venous Thromboembolism Forecast in 24 Major Markets 2018–2028 US$ 5,800.00

... Epiomic Epidemiology Series Forecast Report on Venous Thromboembolism in 24 Major Markets Venous thromboembolism (VTE) is a disease in which thrombi or blood clots form in venous blood ... date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

July 2018 78 pages
Epiomic Epidemiology Series: Acne Vulgaris Forecast in 19 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Acne Vulgaris in 19 Major Markets Acne, or Acne Vulgaris (AV), is a chronic inflammatory disease of the pilosebaceous unit. Although acne can develop at any age, it most ...

June 2018 84 pages
Epiomic Epidemiology Series: Atopic Dermatitis Forecast in 21 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Atopic Dermatitis in 21 Major Markets Atopic Dermatitis, also known as eczema, is a common ... specific co-morbid conditions on Atopic Dermatitis prevalent population. Identify sub-populations within Atopic Dermatitis which require treatment. Gain ...

June 2018 92 pages
Epiomic Epidemiology Series: Fabry Disease Forecast in 21 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Fabry Disease in 21 Major Markets Fabry disease is a lysosomal storage disorder, caused by a ... from specific co-morbid conditions on Fabry disease prevalent population. Identify sub-populations within Fabry disease which require treatment. Gain ...

June 2018 74 pages
Epiomic Epidemiology Series: Frontotemporal Lobe Dementia Forecast in 19 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Frontotemporal Lobe Dementia in 19 Major Markets Frontotemporal lobe dementia (FTD) is a progressive degenerative disorder characterised by degeneration and atrophy of ...

June 2018 70 pages
Epiomic Epidemiology Series: Gaucher’s Disease Forecast in 30 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Gaucher’s Disease in 30 Major Markets Gaucher’s Disease (GD) is caused by an inherited, autosomal recessive mutation in ... date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the ...

June 2018 120 pages
Epiomic Epidemiology Series: Hidradenitis Suppurativa Forecast in 21 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Forecast Report on Hidradenitis Suppurativa in 21 Major Markets Hidradenitis suppurativa (HS) is a chronic multifactorial inflammatory skin disease with ... information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

June 2018 88 pages
Epiomic Epidemiology Series: Mucopolysaccharidosis Type VI Forecast in 30 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Forecast Report on Mucopolysaccharidosis Type VI in 30 Major Markets Mucopolysaccharidosis type VI (MPS VI), also known as Maroteaux–Lamy syndrome, is ... date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

June 2018 86 pages
Epiomic Epidemiology Series: Onychomycosis Forecast in 22 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Onychomycosis in 22 Major Markets Onychomycosis is a fungal infection of the nail which occurs in ... country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Onychomycosis include: Diabetes Tinea pedis Peripheral ...

June 2018 100 pages
Epiomic Epidemiology Series: Tay–Sachs Disease Forecast in 19 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Tay Sachs Disease (TSD) in 19 Major Markets Hexosaminidase A deficiency (HEX A deficiency) results in a ... with biological functions. The predominant HEX A deficiency is Tay-Sachs disease (TSD) with its common acute infantile variant, which ...

June 2018 78 pages
Epiomic Epidemiology Series: Autosomal Dominant Polycystic Kidney Disease Forecast in 29 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Forecast Report on Autosomal Dominant Polycystic Kidney Disease in 29 Major Markets Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary ... information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

April 2018 92 pages
Epiomic Epidemiology Series: Chronic Pancreatitis Forecast in 23 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Forecast Report on Chronic Pancreatitis in 23 Major Markets Chronic pancreatitis (CP) is a persistent low- ... conditions on the prevalent population of chronic pancreatitis patients. Identification of chronic pancreatitis patient sub-populations that require treatment. ...

April 2018 74 pages
Epiomic Epidemiology Series: Mucopolysaccharidosis Type I Forecast in 27 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Forecast Report on Mucopolysaccharidosis Type I in 27 Major Markets Mucopolysaccharidosis type I (MPS I) is a recessively inherited autosomal genetic disorder ... information form patient registries, clinical trials and epidemiology studies. All of the sources used to ...

April 2018 74 pages
Epiomic Epidemiology Series: Mucopolysaccharidosis Type IV Forecast in 28 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Forecast Report on Mucopolysaccharidosis Type IV in 28 Major Markets Mucopolysaccharidosis type IV (MPS IV), also known as Morquio syndrome, is an ... date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

April 2018 88 pages
Epiomic Epidemiology Series: X-linked Hypophosphataemia Forecast in 20 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Forecast Report on X-Linked Hypophosphataemia in 20 Major Markets X-linked hypophosphataemia (XLH) is the most common inherited form of hypophosphataemic rickets, a diverse ...

April 2018 64 pages
Epiomic Epidemiology Series: Autism Spectrum Disorders Forecast in 22 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Forecast Report on Autism Spectrum Disorders in 22 Major Markets Autism Spectrum Disorders (ASD) or Pervasive Developmental ... on the prevalent population of autism spectrum disorder patients. Identification of autism spectrum disorder patient sub-populations that ...

March 2018 88 pages
Epiomic Epidemiology Series: Epilepsy Forecast in 19 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Forecast Report on Epilepsy in 19 Major Markets Epilepsy is a complex neurologic disorder characterised by the occurrence ... a country level across the 10-year forecast snapshot. Main co-morbidities of epilepsy include: Behavioural and psychiatric disorders Neurological ...

March 2018 86 pages
Epiomic Epidemiology Series: Huntington’s DISEASE Forecast in 20 Major Markets 2018–2028 US$ 5,800.00

Black Swan Analysis Epiomic Epidemiology Forecast Report on Huntington’s disease in 20 Major Markets Huntington’s disease (HD) is a rare hereditary genetic disorder of ...